Wells Fargo’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.94M | Buy |
51,924
+37,093
| +250% | +$2.47M | ﹤0.01% | 2859 |
|
|
2026
Q1 | $727K | Sell |
14,831
-28,430
| -66% | -$988K | ﹤0.01% | 3935 |
|
|
2025
Q4 | $1.31M | Buy |
43,261
+22,405
| +107% | +$624K | ﹤0.01% | 3758 |
|
|
2025
Q3 | $401K | Buy |
20,856
+3,401
| +19% | +$50.4K | ﹤0.01% | 4459 |
|
|
2025
Q2 | $196K | Buy |
+17,455
| New | +$182K | ﹤0.01% | 4788 |
|
|
2024
Q2 | – | Sell |
-7
| Closed | -$279 | – | 6855 |
|
|
2024
Q1 | $141 | Hold |
7
| – | – | ﹤0.01% | 6583 |
|
|
2023
Q4 | $134 | Buy |
7
+1
| +17% | +$22 | ﹤0.01% | 6699 |
|
|
2023
Q3 | $151 | Sell |
6
-3
| -33% | -$73 | ﹤0.01% | 6649 |
|
|
2023
Q2 | $211 | Buy |
9
+1
| +13% | +$25 | ﹤0.01% | 6687 |
|
|
2023
Q1 | $199 | Hold |
8
| – | – | ﹤0.01% | 6773 |
|
|
2022
Q4 | $232 | Hold |
8
| – | – | ﹤0.01% | 6583 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 7522 |
|
|
2022
Q2 | $0 | Buy |
8
+1
| +14% | +$28 | ﹤0.01% | 7647 |
|
|
2022
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 7978 |
|
|
2021
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 7930 |
|
|
2021
Q3 | $0 | Sell |
7
-6
| -46% | -$222 | ﹤0.01% | 7633 |
|
|
2021
Q2 | $0 | Buy |
13
+8
| +160% | +$334 | ﹤0.01% | 7567 |
|
|
2021
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 7492 |
|
|
2020
Q4 | $0 | Buy |
5
+2
| +67% | +$100 | ﹤0.01% | 7128 |
|
|
2020
Q3 | $0 | Buy |
3
+2
| +200% | +$141 | ﹤0.01% | 7023 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6936 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$54 | ﹤0.01% | 6924 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | – | – | 6379 |
|
|
2016
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6371 |
|
|
2016
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6483 |
|
|
2015
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 6120 |
|
|
2015
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 6088 |
|
|
2015
Q2 | $1K | Buy |
+1
| New | +$1.31K | ﹤0.01% | 6267 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6402 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6457 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6382 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6325 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6113 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5962 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5877 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5719 |
|
Other funds holding ORKA
VA
FFM
RI
PBA
DTC
Wells Fargo's ORKA Position: Q2 2026 in Review
Wells Fargo increased its Oruka Therapeutics (ORKA) stake by 250% in Q2 2026, buying an estimated $2.47M and bringing the position to 51,924 shares worth $4.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2859.
Wells Fargo first reported a position in ORKA in Q2 2015 and has held it in 27 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.
- Wells Fargo held 51,924 shares of Oruka Therapeutics worth $4.94M as of Q2 2026.
- Wells Fargo bought 37,093 Oruka Therapeutics shares in Q2 2026, an estimated $2.47M.
- Oruka Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2859 holding.
- Wells Fargo first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 27 quarters since.
- 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.